|
|
||||||||
Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St. Louis, Missouri
Cardiovascular Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri
Correspondence: For reprints contact: Robert J. Gropler, MD, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Blvd., St. Louis, MO 63110.
ABSTRACT
In initial studies using fluorine-18-fluorodeoxyglucose (FDG) in normal fasted subjects, we observed disparities in the regional myocardial accumulation of this tracer. Accordingly, we systematically evaluated regional myocardial FDG accumulation in comparison with regional myocardial perfusion assessed with oxygen-15-water and oxidative metabolism assessed with carbon-11-acetate in nine normal subjects (four studied after a 5-hr fast and five studied both fasted and following glucose loading). Under fasting conditions, myocardial accumulation of FDG in the septum and anterior wall averaged 80% of that in the lateral and posterior walls (p < 0.03). In contrast, after glucose loading the regional distribution of myocardial FDG accumulation became more homogeneous. Regional myocardial perfusion, oxidative metabolism, and accumulation of carbon-11-acetate were homogeneous under both conditions. Thus, under fasting conditions there are regional variations in myocardial accumulation of FDG, which are visually apparent, are not associated with concomitant changes in oxidative metabolism or perfusion, and cannot be attributed to partial-volume effects. This significant heterogeneity may limit the specificity of PET with FDG for detecting myocardial ischemia in fasting subjects.
This article has been cited by other articles:
![]() |
E. Inglese, L. Leva, R. Matheoud, G. Sacchetti, C. Secco, P. Gandolfo, M. Brambilla, and G. Sambuceti Spatial and Temporal Heterogeneity of Regional Myocardial Uptake in Patients Without Heart Disease Under Fasting Conditions on Repeated Whole-Body 18F-FDG PET/CT J. Nucl. Med., October 1, 2007; 48(10): 1662 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Israel, M. Weiler-Sagie, S. Rispler, R. Bar-Shalom, A. Frenkel, Z. Keidar, A. Bar-Shalev, and H. W. Strauss PET/CT Quantitation of the Effect of Patient-Related Factors on Cardiac 18F-FDG Uptake J. Nucl. Med., February 1, 2007; 48(2): 234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Fukuchi, H Ohta, K Matsumura, and Y Ishida Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies Br. J. Radiol., January 1, 2007; 80(949): 3 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishimaru, I. Tsujino, T. Takei, E. Tsukamoto, S. Sakaue, M. Kamigaki, N. Ito, H. Ohira, D. Ikeda, N. Tamaki, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur. Heart J., August 1, 2005; 26(15): 1538 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taylor, T. R. Wallhaus, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone An Evaluation of Myocardial Fatty Acid and Glucose Uptake Using PET with [18F]Fluoro-6-Thia-Heptadecanoic Acid and [18F]FDG in Patients with Congestive Heart Failure J. Nucl. Med., January 1, 2001; 42(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jadvar, H. W. Strauss, and G. M. Segall SPECT and PET in the Evaluation of Coronary Artery Disease RadioGraphics, July 1, 1999; 19(4): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Yamagishi, K Akioka, M Takagi, A Tanaka, K Takeuchi, J Yoshikawa, and H Ochi Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction Heart, January 1, 1999; 81(1): 17 - 24. [Abstract] [Full Text] |
||||
![]() |
M. Maki, M. Luotolahti, P. Nuutila, H. Iida, L.-M. Voipio-Pulkki, U. Ruotsalainen, M. Haaparanta, O. Solin, J. Hartiala, R. Harkonen, et al. Glucose Uptake in the Chronically Dysfunctional but Viable Myocardium Circulation, May 1, 1996; 93(9): 1658 - 1666. [Abstract] [Full Text] |
||||
![]() |
J. vom Dahl, O. Muzik, E. R. Wolfe Jr, C. Allman, G. Hutchins, and M. Schwaiger Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability Circulation, January 15, 1996; 93(2): 238 - 245. [Abstract] [Full Text] |
||||
![]() |
N. Tamaki, M. Kawamoto, E. Tadamura, Y. Magata, Y. Yonekura, R. Nohara, S. Sasayama, K. Nishimura, T. Ban, and J. Konishi Prediction of ReversibleIschemia After Revascularization : Perfusion and Metabolic Studies WithPositron Emission Tomography Circulation, March 15, 1995; 91(6): 1697 - 1705. [Abstract] [Full Text] |
||||
![]() |
P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D. J. Betteridge, E. Ferrannini, and P. G. Camici Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1163 - E1171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |